The recent study found the addition of microbiome analysis helped identify high-risk patients, who should undergo colonoscopy screening. The study’s authors concluded that microbiome analysis should be used in conjunction with FOBT, rather than as a replacement.
More articles on gastroenterology:
Financial leadership playbook: The essential skills for a CFO in gastroenterology
Higher Medicaid reimbursement associated with higher cancer screening rates
The biggest threats to success in the GI field
